Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

rmtD2, a New Allele of a 16S rRNA Methylase Gene, Has Been Present in Enterobacteriaceae Isolates from Argentina for More than a Decade

Nathalie Tijet, Patricia Andres, Catherine Chung, Celeste Lucero, ; WHONET-Argentina Group , Donald E. Low, Marcelo Galas, Alejandra Corso, Alejandro Petroni, Roberto G. Melano
Nathalie Tijet
1Ontario Agency for Health Protection and Promotion, Public Health Laboratories, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Andres
2Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas—ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Chung
1Ontario Agency for Health Protection and Promotion, Public Health Laboratories, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celeste Lucero
2Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas—ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald E. Low
1Ontario Agency for Health Protection and Promotion, Public Health Laboratories, Toronto, ON, Canada
3Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
4Department of Microbiology, Mount Sinai Hospital, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo Galas
2Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas—ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandra Corso
2Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas—ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro Petroni
2Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas—ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto G. Melano
1Ontario Agency for Health Protection and Promotion, Public Health Laboratories, Toronto, ON, Canada
3Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
4Department of Microbiology, Mount Sinai Hospital, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: roberto.melano@oahpp.ca
DOI: 10.1128/AAC.00962-10
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The first allele of a 16S rRNA methyltransferase gene, rmtD2, conferring very high resistance to all clinically available aminoglycosides, was detected in 7/1,064 enterobacteria collected in 2007. rmtD2 was located on a conjugative plasmid in a Tn2670-like element inside a structure similar to that of rmtD1 but probably having an independent assembly. rmtD2 has been found since 1996 to 1998 mainly in Enterobacter and Citrobacter isolates, suggesting a possible reservoir in these genera. This presumption deserves monitoring by continuous surveillance.

Posttranscriptional methylation of the 16S rRNA aminoglycoside binding site, common in aminoglycoside-producing microorganisms, has been described in nosocomial isolates highly resistant to all clinically available aminoglycosides. Currently, seven plasmid-mediated 16S rRNA methyltransferase (16S-methylase) genes have been identified: armA, npmA, rmtA, rmtB, rmtC, rmtD (named rmtD1 herein), and very recently, rmtE, from bovine origin (3, 4, 19). To date, only Klebsiella pneumoniae harboring rmtD1 has been reported in Argentina (7). Herein, a nationwide survey of aminoglycoside resistance mediated by 16S-methylases among enterobacteria in Argentina was performed.

(Preliminary data were presented in abstract form at the 109th General Meeting, American Society for Microbiology, 2009, and at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2010.)

Susceptibility and molecular detection of resistance mechanisms.

To determine the prevalence of the 16S-methylases, a collection of 1,064 consecutive, nonduplicate enterobacterial isolates was analyzed. This sample set was collected during a 5-day period in 2007 from 66 hospitals belonging to the WHONET-Argentina Resistance Surveillance Network and submitted to the Servicio Antimicrobianos (the Argentinian National Reference Laboratory). Initial screening of 16S-methylase activity was performed using the disc diffusion susceptibility method for amikacin and gentamicin (inhibition zones of ≤10 mm) (1, 4). Although almost 80% of the collection was made up of Escherichia coli and Klebsiella spp., only 12 isolates belonging to other species (4 Enterobacter cloacae, 1 Enterobacter aerogenes, 3 Serratia species, 2 Citrobacter freundii, 1 Morganella morganii, and 1 Proteus mirabilis isolate) met the screening criteria used. Of these, 5 showed inhibition zones of ≥7 mm to amikacin, and 7 (all of the Enterobacter species and C. freundii isolates) showed an absence of inhibition zones for both aminoglycosides. Only these last 7 isolates gave positive results when tested for 16S-methylase genes by PCR (Table 1), and only the primers against rmtD genes rendered amplicons (Table 2). Complete gene amplification and DNA sequencing showed a unique 16S-methylase gene in these 7 isolates. This gene displayed 97.3% nucleotide identity (20 nucleotides of difference) and 96.4% amino acid identity (9 residues of difference) with rmtD1. Since this is the first description of a 16S-methylase gene allele, it was named rmtD2, as recommended by Doi and colleagues (6). The rmtD2-harboring isolates were from 6 hospitals in 4 geographic areas across Argentina, and pulsed-field gel electrophoresis (PFGE) of XbaI-digested DNA of the 4 E. cloacae and 2 C. freundii isolates showed that they were not clonally related (data not shown).

View this table:
  • View inline
  • View popup
TABLE 1.

Sequences of primers used for specific gene detection

View this table:
  • View inline
  • View popup
TABLE 2.

Antimicrobial susceptibility and molecular typing of resistance mechanisms of clinical isolates and transconjugant strains

Antibiotic MICs, except that of apramycin (agar dilution method [1]), were determined by Etest (AB bioMérieux, Solna, Sweden). The 7 rmtD2-harboring isolates showed high MICs to all of the aminoglycosides tested except apramycin (Table 2). These results were comparable with those of Fritsche and colleagues for enterobacteria producing different enzymes that methylate the 16S rRNA at position G1405 (7). Conversely, Wachino and colleagues described NpmA, which methylates at position A1408, conferring intermediate resistance to amikacin (16 μg/ml) and low-level resistance to gentamicin (32 μg/ml) but high-level resistance to apramycin (>256 μg/ml) (19). Taken together, these data suggest that the new variant RmtD2 methylates at position G1405. Moreover, our phenotypic results support the approach of Doi and Arakawa for detecting the 16S-methylases that act at that last position (4).

The rmtD2-harboring isolates displayed other resistance mechanisms (Table 2). Under the new carbapenem breakpoints (2), all 7 clinical strains showed resistance/intermediate resistance to ertapenem, and several of them showed intermediate resistance to imipenem and/or meropenem. This is probably due to impermeability combined with hyperproduced AmpC and/or CTX-M-type enzymes (11, 16). Production of metallo-β-lactamases was discarded by EDTA-sodium mercaptoacetic acid (SMA) phenotypic screening (8). All of the isolates were resistant to ciprofloxacin (Q4079 showed reduced susceptibility), tetracycline, and chloramphenicol as well. Biparental conjugations were performed between each rmtD2-harboring clinical isolate and sodium azide-resistant E. coli J53 or rifampin- and nalidixic acid-resistant E. coli ER1793 as recipients, using amikacin (50 μg/ml) and gentamicin (50 μg/ml) plus sodium azide (100 μg/ml) or rifampin (300 μg/ml), respectively, to select the transconjugants. All conjugations rendered rmtD2-harboring transconjugants highly resistant to aminoglycosides (Table 2). Resistance to ampicillin, piperacillin, extended-spectrum cephalosporins, and chloramphenicol was cotransferred to E. coli in some cases. Transmission of reduced susceptibility to ciprofloxacin was observed in the transconjugant J-4143. The characterization of relevant genetic determinants responsible for these resistant phenotypes, such as blaTEM-1, blaCTX-M-2, and qnrB10, was performed by PCR and DNA sequencing (Tables 1 and 2). Therefore, RmtD2 was coexpressed with, but not necessarily linked to, other resistance mechanisms.

rmtD2 flanking regions.

XbaI DNA libraries from E. cloacae Q4010, E. aerogenes Q4079, and C. freundii Q1174 were generated in E. coli TOP10 using the cloning vector pACYC184. The rmtD2-harboring clones were selected with chloramphenicol (34 μg/ml), gentamicin, and kanamycin (4 μg/ml each), and DNA inserts were sequenced using pACYC184-specific and sequence-based primers. The inserts from isolates Q4010 and Q1174 were completely sequenced, while a 19.7-kb partial sequence was obtained from a longer fragment of Q4079. The genetic environments of rmtD2 in these three isolates differed only in the cassette arrays of the class 1 integrons and showed the same ISCR14-bracketed genetic architecture as those surrounding rmtD1 in Pseudomonas aeruginosa PA0905 and K. pneumoniae R2 from Brazil (5) (Fig. 1 A). However, several key differences between the environments of rmtD1 and rmtD2 were found (Fig. 1B to D). We concluded that the ISCR14-bracketed structures surrounding rmtD1 and rmtD2 are composed of very similar blocks of genes but having different edges. Moreover, it is noteworthy that the second ISCR14 in E. aerogenes Q4079, named herein ISCR14B, is actually a chimera, since the last 337 nucleotides of orf494 and its 256-bp downstream sequence to oriIS showed a maximal identity of 96% with ISCR5B (GenBank accession no. AM849110) but only 79% with ISCR14 (9). Therefore, ISCR14B might have resulted from a recombination between two ISCRs (e.g., ISCR14 and ISCR5B), as has already been reported for ISCR5B, which is itself a chimeric element (9). All of the data strongly suggest that the ISCR14-bracketed region found in the enterobacterial isolates from Argentina and that in P. aeruginosa PA0905 from Brazil were assembled in independent processes through a series of ISCR transposition/homologous recombination events rather than variants derived from a common original structure. This is similar to the proposed model of the ISCR19-bracketed blaOXA-18 structure (12).

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Schematic representation of the genetic platform of rmtD2. (A) Comparison of the fragments harboring rmtD2 in E. aerogenes Q4079 and C. freundii Q1174 or E. cloacae Q4010 with the genetic environment of rmtD1 in P. aeruginosa PA0905 (5). The gray-shaded areas indicate nucleotide identity. Regions 1, 2, and 3 (framed by dotted lines), which included key differences between both genetic platforms, are depicted in more detail in panels B, C, and D, respectively. The broad horizontal arrows indicate genes and their transcriptional orientations. The attI and attC sites of class 1 integrons are symbolized by open circles. The black and white triangles represent oriIS and terIS, respectively. The thick lines with single or double arrowheads indicate the insertion elements (ISs) and transposons found (black vertical bars show inverted repeats [IRs]). (B) Region 1. A gap (dashed line) was introduced to maximize the alignment, and the numbers (nucleotides) indicate fragment lengths. The last nucleotides of sul1 are shown for each class 1 integron (sequences are not to scale). The black bar and the thick line indicate the sequences downstream to sul1, i.e., the end of the 3′ conserved sequence (3′CS) and a sequence without significant similarity in GenBank, respectively. The white triangle represents the terIS found only in E. aerogenes Q4079, and its sequence is shown (arrows indicate IRs). (C) Region 2. The dashed line and numbers are described for panel B. The black triangles represent oriISs. (D) Region 3. The dashed line and numbers are described for panel B. The thick line indicates a sequence without significant similarity in GenBank. ΔgroEL genes are not to scale, and the number of amino acids (aa) of each putative encoding protein is shown.

To the best of our knowledge, this is the first report of a 16S-methylase gene linked to a Tn21-like element (Fig. 1A). Another Tn21-like transposon containing the same class 1 integron (dfrA12-orfF-aadA2) as that found in E. aerogenes Q4079 was previously described in a 65-kb conjugative plasmid from a fecal E. coli isolate (20). Unlike in this plasmid, the Tn21-like element of Q4079 has its terminal inverted repeat at the tnp end (TIRtnp21) disrupted by the insertion of IS4321R (Fig. 1A). However, it was shown that the precise excision of IS4321 can re-create the original TIRtnp21, allowing Tn21 transposition (14). In E. aerogenes Q4079, the Tn21-like element is inserted in the same genetic context as Tn21 in the 94-kb multiresistant plasmid NR1 (R100) of Shigella flexneri, i.e., upstream of the ybjA gene and disrupting a Tn9 homolog (10, 20) (Fig. 1A). Since the Tn21-harboring Tn9 element of NR1 is itself transposable as Tn2670 (10), the location of rmtD2 in a putative Tn2670-like element constitutes another potential means of dissemination. In summary, the finding of rmtD2 in this genetic context suggests that its dissemination could be highly facilitated.

Prevalence of rmtD2.

We observed an rmtD2 prevalence of 0.7% in Enterobacteriaceae. Considering the distribution of species in the collection studied, the prevalence rates of this gene were 9.3% in Enterobacter spp. and 13.3% in Citrobacter spp. To better estimate these rates across a broader time period, an analysis of the WHONET-Argentina database (year 2007, 19,077 enterobacteria) was performed. The total correlation between the presence of rmtD2 and the absence of inhibition zones for both amikacin and gentamicin was used as an indicator of the presence of this gene. As observed in the surveillance collection, the overall prevalence of rmtD2 was low (2.1%) but significantly higher in Enterobacter spp. and Citrobacter spp. than in other enterobacteria (Table 3), suggesting a possible reservoir in these species.

View this table:
  • View inline
  • View popup
TABLE 3.

Analysis of Enterobacteriaceae from WHONET-Argentina database, 2007

In order to establish a continuous surveillance, the National Reference Laboratory had recommended to the WHONET-Argentina hospitals to search for enterobacterial isolates showing an absence of inhibition zones for both amikacin and gentamicin. Twelve strains (4 E. cloacae, 1 Enterobacter agglomerans, 1 C. freundii, 4 K. pneumoniae, and 2 P. mirabilis strains), isolated from January 2008 to April 2009, were selected for molecular characterization. By PCR screening, 10/12 isolates were positive only for rmtD genes. The 2 P. mirabilis isolates were negative for all of the 16S-methylase genes tested and remain under study. By sequencing, rmtD1 was found in 2 K. pneumoniae isolates, while rmtD2 was observed in the remaining 8 isolates.

rmtD2 has been present in Argentina for more than a decade.

The first 16S-methylase producer described in Argentina was a K. pneumoniae strain isolated in 2005 (7). To determine whether this resistance mechanism was present earlier, 153 AmpC-producing enterobacterial strains isolated in 1996 to 1998 from a previous national survey were analyzed (15). Thirteen isolates (1 Enterobacter sp., 8 E. cloacae, 3 C. freundii, and 1 Serratia marcescens isolate) were highly resistant to amikacin and gentamicin (MICs of >256 μg/ml). Four of them (2 E. cloacae, 1 C. freundii, and 1 S. marcescens isolate), selected for 16S-methylase gene characterization, showed rmtD2 only. These results point out the presence of rmtD2 in Enterobacter spp. and C. freundii isolated in the 1990s and strengthen the hypothesis of a reservoir in these species, with a further dissemination to other enterobacteria, such as K. pneumoniae. This presumption indicates that continued surveillance is necessary to monitor the spread of rmtD genes.

Nucleotide sequence accession numbers.The nucleotide sequences determined here have been assigned GenBank accession numbers HQ401565 (E. aerogenes Q4079), HQ401566 (E. cloacae Q4010), and HQ401567 (C. freundii Q1174).

ACKNOWLEDGMENTS

This work was supported in part by a start-up grant from the Ontario Agency for Health Protection and Promotion and by the grant Dr. César Milstein, Ministry of Science, Technology and Productive Innovation, Government of Argentina, to R.G.M.

WHONET-Argentina participants include the following: Daniela Ballester, Hospital Piñero; Ana Di Martino, Sanatorio de la Trinidad Mitre; Laura Errecalde, Hospital Fernández; Angela Famiglietti, Hospital de Clínicas; Analía Fernández, Hospital Universitario Fundación Favaloro; Nora Gomez, Hospital Argerich; Horacio Lopardo, Hospital de Pediatría Garrahan; Nora Orellana, FLENI; Adriana Procopio, Hospital de Niños Gutiérrez; Mirta Quinteros, Hospital Muñiz (all in the city of Buenos Aires); Adriana Di Bella, Hospital Posadas, El Palomar; Diana Gómez, Instituto Nacional de Epidemiología Juan Jara, Mar del Plata; Mónica Machain, Hospital Piñeyro, Junín; Andrea Pacha, Hospital San Juan de Dios, La Plata; Susana Palombarani, Hospital Eva Peron, San Martín; Ana Togneri, Hospital Evita, Lanús; Susana Vaylet, Hospital Penna, Bahía Blanca, and Cecilia Vescina, Hospital de Niños Sor Maria Ludovica, La Plata (all in the province of Buenos Aires); Viviana David, Hospital Interzonal San Juan Bautista, and Patricia Valdez, Hospital de Niños Eva Perón, Catamarca; Norma Cech, Hospital 4 de Junio-Ramón Carrillo, Pte. Roque Saenz Peña, and Bettina Irigoyen, Hospital Perrando, Resistencia, Chaco; Omar Daher, Hospital Zonal de Esquel, Chubut; Claudia Aimaretto, Hospital Regional de Villa María; Marina Bottiglieri, Clínica Reina Fabiola; Catalina Culasso, Hospital de Niños de la Santísima Trinidad; Liliana González, Hospital Infantil Municipal; Ana Littvik, Hospital Rawson, and Lidia Wolff, Clínica Privada Vélez Sársfield, city of Córdoba (all in the province of Córdoba); Ana María Pato, Hospital Llano, and Viviana García Saitó, Hospital Pediátrico Juan Pablo II, Corrientes; María Moulins, Hospital Masvernat, Concordia; Humberto Musa, Centro de Microbiología Médica, Paraná, and Francisco Salamone, Hospital San Martín, Paraná, Entre Ríos; Nancy Pereira, Hospital Central de Formosa, and María Vivaldo, Hosp. de la Madre y el Niño, Formosa; Marcelo Toffoli, Hospital de Niños Quintana, and Maria Weibel, Hospital Pablo Soria, Jujuy; Gladys Almada, Hospital Molas, Santa Rosa, and Adriana Pereyra, Hospital Centeno, Gral. Pico, La Pampa; Sonia Flores, Hospital Vera Barros, La Rioja; Lorena Contreras, Hospital Central de Mendoza, and Beatriz García, Hospital Pediátrico Notti, Mendoza; Ana María Miranda, Hospital SAMIC El Dorado, Misiones; María Rosa Núñez, Hospital Castro Rendón, and Herman Sauer, Hospital Heller, Neuquén; Néstor Blázquez, Hospital Carrillo, Bariloche, and Cristina Carranza, Hospital Cipolletti, Río Negro; María Luisa Cacace, Hospital San Vicente de Paul, Orán, and Jorgelina Mulki, Hospital Materno Infantil, Salta; Roberto Navarro, Hospital Rawson, and Nancy Vega, Hospital Marcial Quiroga, San Juan; Ema Fernández, Policlinico Regional J.D. Peron, Villa Mercedes, and Hugo Rigo, Policlínico Central de San Luis, province of San Luis; Wilma Krause, Hospital Regional, Río Gallegos, and Josefina Villegas, Hospital Zonal de Caleta Olivia, Santa Cruz; María Baroni, Hospital de Niños Alassia, and Emilce de los Angeles Méndez, Hospital Cullen, city of Santa Fe; Isabel Bogado, Facultad de Bioquímica, Noemí Borda, Hospital Español, and Adriana Ernst, Hospital de Niños Vilela, Rosario, province of Santa Fe; Ana María Nanni de Fuster, Hospital Regional Ramón Carrillo, Santiago del Estero; Iván Gramundi, Hospital Regional de Ushuaia, and Marcela Vargas, Hospital Regional de Río Grande, Tierra del Fuego; and José Assa, Hospital del Niño Jesús, and Amalia del Valle Amilaga, Hospital Padilla, Tucumán.

We are indebted to D. Faccone, L. Guerriero, and M. Rapoport for technical assistance and to J. Guthrie for a critical reading of the manuscript. We are grateful to Y. Arakawa, Y. Doi, J. Iredell, M. Galimand, T. Fritsche, and M. Castanheira for supplying the 16S-methylase gene positive controls.

FOOTNOTES

    • Received 14 July 2010.
    • Returned for modification 1 August 2010.
    • Accepted 7 November 2010.
    • Accepted manuscript posted online 15 November 2010.
  • Copyright © 2011, American Society for Microbiology

REFERENCES

  1. 1.↵
    Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement M100-S17. Vol. 27, no. 1. Clinical and Laboratory Standards Institute, Wayne, PA.
  2. 2.↵
    Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement (June 2010 update) M100-S20-U. Vol. 30, no. 15. Clinical and Laboratory Standards Institute, Wayne, PA.
  3. 3.↵
    Davis, M. A., et al. 2010. Discovery of a gene conferring multiple-aminoglycoside resistance in Escherichia coli. Antimicrob. Agents Chemother. 54:2666-2669.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Doi, Y., and Y. Arakawa. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides Clin. Infect. Dis. 45:88-94.
    OpenUrlCrossRef
  5. 5.↵
    Doi, Y., J. M. Adams-Haduch, and D. L. Paterson. 2008. Genetic environment of 16S rRNA methylase gene rmtD. Antimicrob. Agents Chemother. 52:2270-2272.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Doi, Y., J. Wachino, and Y. Arakawa. 2008. Nomenclature of plasmid-mediated 16S rRNA methylases responsible for panaminoglycoside resistance. Antimicrob. Agents Chemother. 52:2287-2288.
    OpenUrlFREE Full Text
  7. 7.↵
    Fritsche, T. R., M. Castanheira, G. H. Miller, R. N. Jones, and E. S. Armstrong. 2008. Detection of methyltransferases conferring high-level resistance to aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America. Antimicrob. Agents Chemother. 52:1843-1845.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Lee, K., Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Li, H., T. R. Walsh, and M. A. Toleman. 2009. Molecular analysis of the sequences surrounding blaOXA-45 reveals acquisition of this gene by Pseudomonas aeruginosa via a novel ISCR element, ISCR5. Antimicrob. Agents Chemother. 53:1248-1251.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Liebert, C. A., R. M. Hall, and A. O. Summers. 1999. Transposon Tn21, flagship of the floating genome. Microbiol. Mol. Biol. Rev. 63:507-522.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Livermore, D. M., and N. Woodford. 2006. The ß-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14:413-420.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Naas, T., et al. 2008. Genetic structure associated with blaOXA-18, encoding a clavulanic acid-inhibited extended-spectrum oxacillinase. Antimicrob. Agents Chemother. 52:3898-3904.
    OpenUrlAbstract/FREE Full Text
  13. 13.
    Pallecchi, L., et al. 2004. Detection of CTX-M-type ß-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob. Agents Chemother. 48:4556-4561.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Partridge, S. R., and R. M. Hall. 2003. The IS1111 family members IS4321 and IS5075 have subterminal inverted repeats and target the terminal inverted repeats of Tn21 family transposons. J. Bacteriol. 185:6371-6384.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Pasterán, F., et al. 1999. High proportion of extended spectrum ß-lactamases (ESBL) among AMP-C producer enterobacteria in Argentina, abstr. C2-1475. Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
  16. 16.↵
    Pasterán, F., T. Mendez, M. Rapoport, L. Guerriero, and A. Corso. 2010. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class A carbapenemase in species of Enterobacteriaceae by incorporating boronic acid. J. Clin. Microbiol. 48:1323-1332.
    OpenUrlAbstract/FREE Full Text
  17. 17.
    Pillai, D. R., et al. 2009. Klebsiella pneumoniae carbapenemase, Canada. Emerg. Infect. Dis. 15:827-829.
    OpenUrlCrossRefPubMed
  18. 18.
    Quiroga, M. P., et al. 2007. Complex class 1 integrons with diverse variable regions, including aac(6′)-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrob. Agents Chemother. 51:4466-4470.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Wachino, K., et al. 2007. Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides. Antimicrob. Agents Chemother. 51:4401-4409.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Williams, L. E., C. Detter, K. Barry, A. Lapidus, and A. O. Summers. 2006. Facile recovery of individual high-molecular-weight, low-copy-number natural plasmids for genomic sequencing. Appl. Environ. Microbiol. 72:4899-4906.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
rmtD2, a New Allele of a 16S rRNA Methylase Gene, Has Been Present in Enterobacteriaceae Isolates from Argentina for More than a Decade
Nathalie Tijet, Patricia Andres, Catherine Chung, Celeste Lucero, Donald E. Low, Marcelo Galas, Alejandra Corso, Alejandro Petroni, Roberto G. Melano WHONET-Argentina Group
Antimicrobial Agents and Chemotherapy Jan 2011, 55 (2) 904-909; DOI: 10.1128/AAC.00962-10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
rmtD2, a New Allele of a 16S rRNA Methylase Gene, Has Been Present in Enterobacteriaceae Isolates from Argentina for More than a Decade
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
rmtD2, a New Allele of a 16S rRNA Methylase Gene, Has Been Present in Enterobacteriaceae Isolates from Argentina for More than a Decade
Nathalie Tijet, Patricia Andres, Catherine Chung, Celeste Lucero, Donald E. Low, Marcelo Galas, Alejandra Corso, Alejandro Petroni, Roberto G. Melano WHONET-Argentina Group
Antimicrobial Agents and Chemotherapy Jan 2011, 55 (2) 904-909; DOI: 10.1128/AAC.00962-10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • Susceptibility and molecular detection of resistance mechanisms.
    • rmtD2 flanking regions.
    • Prevalence of rmtD2.
    • rmtD2 has been present in Argentina for more than a decade.
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596